tiprankstipranks
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
Holding BNGO?
Track your performance easily

BioNano Genomics (BNGO) Financial Statements

9,017 Followers

BioNano Genomics Financial Overview

BioNano Genomics's market cap is currently ―. The company's EPS TTM is $-2.31; its P/E ratio is -0.09; BioNano Genomics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 6.07M$ 7.77M$ 8.77M$ 10.72M$ 9.32M
Gross Profit$ -8.45M$ 2.58M$ 2.82M$ 2.44M$ 2.75M
EBIT$ -44.15M$ -16.12M$ -31.32M$ -39.03M$ -112.46M
EBITDA$ -38.47M$ -12.39M$ -28.95M$ -35.61M$ -108.78M
Net Income Common Stockholders$ -44.25M$ -16.22M$ -31.42M$ -43.89M$ -112.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.00M$ 18.90M$ 28.40M$ 66.70M$ 63.60M
Total Assets$ 87.36M$ 129.36M$ 158.00M$ 214.40M$ 181.90M
Total Debt$ 22.45M$ 27.57M$ 37.87M$ 79.41M$ 10.14M
Net Debt$ 10.45M$ 8.67M$ 9.47M$ 12.71M$ -53.46M
Total Liabilities$ 38.49M$ 49.03M$ 75.22M$ 118.25M$ 62.91M
Stockholders Equity$ 48.87M$ 80.29M$ 82.77M$ 96.16M$ 119.00M
Cash Flow-
Free Cash Flow$ -13.30M$ -21.08M$ -28.13M$ -30.52M$ -26.37M
Operating Cash Flow$ -13.30M$ -21.00M$ -28.10M$ -29.78M$ -26.29M
Investing Cash Flow$ -5.38M$ 28.63M$ 47.59M$ -55.37M$ 33.43M
Financing Cash Flow$ 6.02M$ -1.98M$ -21.62M$ 68.48M$ 12.59M
Currency in USD

BioNano Genomics Earnings and Revenue History

BioNano Genomics Debt to Assets

BioNano Genomics Cash Flow

BioNano Genomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis